95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-23.42%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-18.86%
Negative gross profit growth while NEM is at 1.88%. Joel Greenblatt would examine cost competitiveness or demand decline.
-23.52%
Negative EBIT growth while NEM is at 51.32%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-23.52%
Negative operating income growth while NEM is at 51.32%. Joel Greenblatt would press for urgent turnaround measures.
463.45%
Net income growth above 1.5x NEM's 113.66%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
460.00%
EPS growth above 1.5x NEM's 113.85%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
460.00%
Diluted EPS growth above 1.5x NEM's 113.85%. David Dodd would see if there's a robust moat protecting these shareholder gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Dividend reduction while NEM stands at 3.31%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-31.36%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-31.00%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
124.38%
10Y revenue/share CAGR above 1.5x NEM's 11.98%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
-20.60%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-3.10%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
100.65%
10Y OCF/share CAGR under 50% of NEM's 445.19%. Michael Burry would worry about a persistent underperformance in cash creation.
-41.38%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-15.46%
Negative 3Y OCF/share CAGR while NEM stands at 93.98%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
22.82%
Positive 10Y CAGR while NEM is negative. John Neff might see a substantial advantage in bottom-line trajectory.
-66.69%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-37.90%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
256.57%
Positive growth while NEM is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
44.22%
Positive 5Y equity/share CAGR while NEM is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
17.38%
3Y equity/share CAGR above 1.5x NEM's 0.49%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
43.26%
Our AR growth while NEM is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
No Data
No Data available this quarter, please select a different quarter.
-1.10%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
0.73%
Positive BV/share change while NEM is negative. John Neff sees a clear edge over a competitor losing equity.
-10.81%
We’re deleveraging while NEM stands at 0.13%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
114.57%
SG&A growth of 114.57% while NEM is zero. Bruce Berkowitz sees more spend on admin or marketing, expecting stronger top-line in return.